-
Something wrong with this record ?
HDMX folds the nascent p53 mRNA following activation by the ATM kinase
L. Malbert-Colas, A. Ponnuswamy, V. Olivares-Illana, AS. Tournillon, N. Naski, R. Fåhraeus,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Cell Press Free Archives
from 1997-12-01 to 1 year ago
Free Medical Journals
from 1997 to 1 year ago
Free Medical Journals
from 1997 to 1 year ago
Open Access Digital Library
from 1997-12-01
- MeSH
- Ataxia Telangiectasia Mutated Proteins metabolism MeSH
- Phosphorylation MeSH
- Nuclear Proteins chemistry physiology MeSH
- Humans MeSH
- RNA, Messenger chemistry genetics metabolism MeSH
- Molecular Sequence Data MeSH
- Tumor Suppressor Protein p53 genetics metabolism MeSH
- Inverted Repeat Sequences MeSH
- DNA Damage MeSH
- RNA Processing, Post-Transcriptional MeSH
- Protein Processing, Post-Translational MeSH
- Protein Biosynthesis MeSH
- Proto-Oncogene Proteins c-mdm2 metabolism MeSH
- Proto-Oncogene Proteins chemistry physiology MeSH
- Gene Expression Regulation MeSH
- RNA Folding MeSH
- Base Sequence MeSH
- Sf9 Cells MeSH
- Spodoptera MeSH
- Substrate Specificity MeSH
- Protein Structure, Tertiary MeSH
- Protein Binding MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Regulated protein synthesis via changes in mRNA structures forms an important part of how prokaryotic cells adapt protein expression in response to changes in the environment. Little is known regarding how this concept has adapted to regulate mRNA translation via signaling pathways in mammalian cells. Here, we show that following phosphorylation by the ataxia telangiectasia mutated (ATM) kinase at serine 403, the C-terminal RING domain of HDMX binds the nascent p53 mRNA to promote a conformation that supports the p53 mRNA-HDM2 interaction and the induction of p53 synthesis. HDMX and its homolog HDM2 bind the same p53 internal ribosome entry sequences (IRES) structure but with different specificity and function. The results show how HDMX and HDM2 act as nonredundant IRES trans-acting factors (ITAFs) to bring a positive synergistic effect on p53 expression during genotoxic stress by first altering the structure of the newly synthesized p53 mRNA followed by stimulation of translation.
Instituto de Fisica Universidad Autonoma de San Luis Potosí 78290 San Luis Potosí Mexico
RECAMO Masaryk Memorial Cancer Institute Zluty kopec 7 656 53 Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074215
- 003
- CZ-PrNML
- 005
- 20141009094950.0
- 007
- ta
- 008
- 141006s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.molcel.2014.02.035 $2 doi
- 035 __
- $a (PubMed)24813712
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Malbert-Colas, Laurence $u Cibles Thérapeutiques, Equipe Labellisée Ligue Contre le Cancer, INSERM Unité 940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France.
- 245 10
- $a HDMX folds the nascent p53 mRNA following activation by the ATM kinase / $c L. Malbert-Colas, A. Ponnuswamy, V. Olivares-Illana, AS. Tournillon, N. Naski, R. Fåhraeus,
- 520 9_
- $a Regulated protein synthesis via changes in mRNA structures forms an important part of how prokaryotic cells adapt protein expression in response to changes in the environment. Little is known regarding how this concept has adapted to regulate mRNA translation via signaling pathways in mammalian cells. Here, we show that following phosphorylation by the ataxia telangiectasia mutated (ATM) kinase at serine 403, the C-terminal RING domain of HDMX binds the nascent p53 mRNA to promote a conformation that supports the p53 mRNA-HDM2 interaction and the induction of p53 synthesis. HDMX and its homolog HDM2 bind the same p53 internal ribosome entry sequences (IRES) structure but with different specificity and function. The results show how HDMX and HDM2 act as nonredundant IRES trans-acting factors (ITAFs) to bring a positive synergistic effect on p53 expression during genotoxic stress by first altering the structure of the newly synthesized p53 mRNA followed by stimulation of translation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ATM protein $x metabolismus $7 D064007
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a obrácené repetice $7 D055029
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a jaderné proteiny $x chemie $x fyziologie $7 D009687
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a proteosyntéza $7 D014176
- 650 _2
- $a posttranslační úpravy proteinů $7 D011499
- 650 _2
- $a terciární struktura proteinů $7 D017434
- 650 _2
- $a protoonkogenní proteiny $x chemie $x fyziologie $7 D011518
- 650 _2
- $a protoonkogenní proteiny c-mdm2 $x metabolismus $7 D051736
- 650 _2
- $a sbalování RNA $7 D059370
- 650 _2
- $a posttranskripční úpravy RNA $7 D012323
- 650 _2
- $a messenger RNA $x chemie $x genetika $x metabolismus $7 D012333
- 650 _2
- $a Sf9 buňky $7 D061987
- 650 _2
- $a Spodoptera $7 D018411
- 650 _2
- $a substrátová specifita $7 D013379
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ponnuswamy, Anand $u Cibles Thérapeutiques, Equipe Labellisée Ligue Contre le Cancer, INSERM Unité 940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic.
- 700 1_
- $a Olivares-Illana, Vanesa $u Instituto de Fisica, Universidad Autonoma de San Luis Potosí, 78290 San Luis Potosí, Mexico.
- 700 1_
- $a Tournillon, Anne-Sophie $u Cibles Thérapeutiques, Equipe Labellisée Ligue Contre le Cancer, INSERM Unité 940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France.
- 700 1_
- $a Naski, Nadia $u Cibles Thérapeutiques, Equipe Labellisée Ligue Contre le Cancer, INSERM Unité 940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France.
- 700 1_
- $a Fåhraeus, Robin $u Cibles Thérapeutiques, Equipe Labellisée Ligue Contre le Cancer, INSERM Unité 940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France. Electronic address: robin.fahraeus@inserm.fr.
- 773 0_
- $w MED00011398 $t Molecular cell $x 1097-4164 $g Roč. 54, č. 3 (2014), s. 500-11
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24813712 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141009095338 $b ABA008
- 999 __
- $a ok $b bmc $g 1042098 $s 873127
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 54 $c 3 $d 500-11 $i 1097-4164 $m Molecular cell $n Mol Cell $x MED00011398
- LZP __
- $a Pubmed-20141006